Publications by authors named "Saad Tayyab"

Background: Intranasal drug delivery shows potential for brain access via olfactory and trigeminal routes.

Purpose: This work aimed to ensure brain availability of nalbuphine via the nasal route.

Method: Chitosan based nanoparticles loaded with nalbuphine were successfully prepared using ionic gelation method and characterised.

View Article and Find Full Text PDF

Molecular docking, molecular dynamics (MD) simulation, atomic force microscopy (AFM) and multi-spectroscopic techniques were selected to unveil the molecular association between the hepatitis B virus (HBV) inhibitor, entecavir (ETR), and the major blood plasma transporter, human serum albumin (HSA). The entire docking and simulation analyses recognized ETR binding to subdomain IIA (Site I) of HSA through hydrogen bonds, hydrophobic and van der Waals forces while maintaining the complex's stability throughout the 100 ns. A gradual lessening in the Stern-Volmer quenching constant () with rising temperatures registered ETR-induced quenching of HBV fluorescence as static quenching, thus advising complexation between ETR and HSA.

View Article and Find Full Text PDF

The binding mode of antineoplastic antimetabolite, floxuridine (FUDR), with human serum albumin (HSA), the leading carrier in blood circulation, was ascertained using multi-spectroscopic, microscopic, and computational techniques. A static fluorescence quenching was established due to decreased K values with rising temperatures, suggesting FUDR-HSA complexation. UV-vis absorption spectral results also supported this conclusion.

View Article and Find Full Text PDF

This study explores the plausible molecular interaction between a potent hepatitis C virus inhibitor, PSI-6206 (PSI), and human serum albumin (HSA), a primary transporter in blood plasma. Results obtained from both computational viz. molecular docking and molecular dynamics (MD) simulation and wet lab techniques such as UV absorption, fluorescence, circular dichroism (CD), and atomic force microscopy (AFM) complemented each other.

View Article and Find Full Text PDF
Article Synopsis
  • Pazopanib (PZP) is a tyrosine kinase inhibitor approved by the FDA for soft tissue sarcoma and renal cancer, and its binding mechanism with human serum albumin (HSA) was studied under physiological conditions.
  • The study determined that PZP binds to HSA primarily through hydrophobic interactions and static quenching, with moderate binding affinity indicated by fluorescence and UV-vis absorption spectroscopy.
  • Additionally, PZP showed potential protective effects on HSA against thermal stress and primarily binds to Sudlow's Site I on HSA, as supported by competitive drug displacement tests and molecular docking analysis.
View Article and Find Full Text PDF
Article Synopsis
  • Human serum albumin plays a crucial role in drug transport and pharmacokinetics by binding to various ligands, affecting drug efficacy in the body.
  • Changes in albumin binding due to drug interactions or organ dysfunction can significantly impact how drugs work and lead to clinical implications.
  • The potential for using serum albumin in drug delivery systems is explored, highlighting its versatility and effectiveness in experimental and clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • The interaction between the anticancer drug saracatinib (SCB) and human serum albumin (HSA) was studied using fluorescence and absorption spectroscopy, along with computational methods.
  • Analysis indicated that SCB forms a complex with HSA, highlighted by temperature dependence and absorption spectrum changes.
  • Results showed moderate binding affinity between SCB and HSA, with stabilization from hydrophobic, van der Waals, and hydrogen bonds, while SCB also protected HSA from thermal denaturation and preferred binding at Sudlow's site I.
View Article and Find Full Text PDF

Binding of lumefantrine (LUM), an antimalarial drug to human serum albumin (HSA), the main carrier protein in human blood circulation was investigated using fluorescence quenching titration, UV-vis absorption and circular dichroism (CD) spectroscopy as well as molecular docking. LUM-induced quenching of the protein (HSA) fluorescence was characterized as static quenching, as revealed by the decrease in the value of the Stern-Volmer quenching constant, with increasing temperature, thus suggesting LUM-HSA complex formation. This was also confirmed from the UV-vis absorption spectral results.

View Article and Find Full Text PDF
Article Synopsis
  • The interaction between mefloquine (MEF) and human serum albumin (HSA) was analyzed using various spectroscopic techniques, revealing the formation of a complex due to static quenching of HSA fluorescence by MEF.
  • The binding affinity of MEF to HSA was found to be moderate, with association constants ranging from 3.79-5.73 × 10 M, and the interaction was characterized by hydrogen bonds and hydrophobic forces.
  • Changes in the microenvironment of HSA's aromatic residues and slight alterations in its secondary and tertiary structures were observed, along with improved protein stability and identification of HSA Sudlow's site I as the MEF binding site.
View Article and Find Full Text PDF

Tyrphostin 9 (Tyr 9) is a potent platelet-derived growth factor receptor (PDGFR) inhibitor, which induces apoptosis in various cancer cell types. The binding of Tyr 9 to the major transport protein, human serum albumin (HSA) was investigated using several spectroscopic techniques and molecular docking method. Fluorescence quenching titration results showed progressive decrease in the protein fluorescence with increasing drug concentrations.

View Article and Find Full Text PDF

Molecular interaction of the 3,4-methylenedioxy-β-nitrostyrene (MNS), an inhibitor of platelet aggregation with the main transport protein, albumin from human serum (HSA) was explored using absorption, fluorescence and circular dichroism (CD) spectroscopy in combination with analyses. The MNS-HSA complexation was corroborated from the fluorescence and absorption spectral results. Implication of static quenching mechanism for MNS-HSA system was predicted from the Stern-Volmer constant, temperature relationship as well as the bimolecular quenching rate constant, values.

View Article and Find Full Text PDF

Binding of a potent anticancer agent, ponatinib (PTB) to human serum albumin (HSA), main ligand transporter in blood plasma was analyzed with several spectral techniques such as fluorescence, absorption and circular dichroism along with molecular docking studies. Decrease in the K value with increasing temperature pointed towards PTB-induced quenching as the static quenching, thus affirming complexation between PTB and HSA. An intermediate binding affinity was found to stabilize the PTB-HSA complex, as suggested by the K value.

View Article and Find Full Text PDF

A laboratory exercise on the interaction between the herbicide pendimethalin (PM) and goat serum albumin (GSA), a carrier protein present in mammalian blood circulation, is described. Fluorescence spectroscopy was used to study the binding reaction between PM and GSA. Titration of a constant amount of the protein (GSA) with increasing ligand (PM) concentrations produced a consecutive decrease in the protein's fluorescence.

View Article and Find Full Text PDF
Article Synopsis
  • A new fluorogenic probe using chimeric DNA-templated silver nanoclusters has been created to measure telomerase activity in cancer cells.
  • This method achieves selective quenching of silver nanocluster emissions, indicating telomerase presence through G-quadruplex formation in elongated DNA products.
  • It offers improved sensitivity, faster results, and lower costs compared to the traditional telomeric repeat amplification protocol (TRAP) assay, making it a more efficient tool for cancer research.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the herbicide 2,4-D binds to human serum albumin (HSA) using various spectroscopic and computational techniques.
  • The formation of the 2,4-D-HSA complex was confirmed, revealing a weak binding affinity and identifying hydrophobic, van der Waals, and hydrogen bond interactions as key factors in the binding process.
  • Structural changes in HSA and improved thermal stability upon 2,4-D binding were also observed, with findings suggesting that the herbicide primarily binds at Sudlow's site I on the protein.
View Article and Find Full Text PDF

Background: Champedak galactose-binding (CGB) lectin is a tetrameric protein with noncovalently bound monomers, isolated from Artocarpus integer fruit seeds. We had previously reported existence of a structured monomer and an unfolded monomer of CGB lectin at pH 2.5 and pH 1.

View Article and Find Full Text PDF
Article Synopsis
  • The interaction between the anticancer drug vandetanib (VDB) and the ligand transporter lysozyme (LYZ) was studied using various spectroscopic techniques and computational analysis to confirm their complex formation.
  • The findings revealed that VDB binds to LYZ through weak interactions, characterized by a binding constant and thermodynamic parameters indicating the role of hydrophobic and van der Waals forces, along with hydrogen bonds.
  • Additionally, VDB enhances the thermal stability of LYZ while its binding site is near the LYZ active site, with certain metal ions like Mg, Ba, and Zn disrupting this interaction.
View Article and Find Full Text PDF

Multiple spectroscopic techniques, such as fluorescence, absorption, and circular dichroism along with in silico studies were used to characterize the binding of a potent inhibitor molecule, CCG1423 to the major transport protein, human serum albumin (HSA). Fluorescence and absorption spectroscopic results confirmed CCG1423-HSA complex formation. A strong binding affinity stabilized the CCG1423-HSA complex, as evident from the values of the binding constant (K = 1.

View Article and Find Full Text PDF

Binding studies between a multi-targeted anticancer drug, sunitinib (SU) and human serum albumin (HSA) were made using fluorescence, UV-vis absorption, circular dichroism (CD) and molecular docking analysis. Both fluorescence quenching data and UV-vis absorption results suggested formation of SU-HSA complex. Moderate binding affinity between SU and HSA was evident from the value of the binding constant (3.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined how acid affects the stability of champedak galactose-binding (CGB) lectin, revealing it remains stable until pH 5.0, with some disorder starting at pH 3.5.
  • A significant structural change occurs between pH 3.5 and pH 2.5, where the lectin dissociates from tetramers to monomers, marked by changes in fluorescence signals.
  • At pH 1.5, the monomers unfold further but still retain some structure, and there is potential for refolding when pH drops below 1.5.
View Article and Find Full Text PDF

Interaction of pendimethalin (PM) herbicide with the major transporter in human circulation, human serum albumin (HSA), was studied using fluorescence, circular dichroism (CD), and molecular modeling methods. The attenuation of the fluorescence intensity of HSA in the presence of PM revealed formation of the PM-HSA complex. Analysis of the fluorescence quenching data showed moderately strong binding affinity between PM and HSA.

View Article and Find Full Text PDF

Urea and thermal denaturations of bovine serum albumin (BSA) were studied in the absence and the presence of honey or simulated honey sugar cocktail (SHSC) using far-UV CD and ANS fluorescence spectroscopy. Presence of 20% (w/v) honey or SHSC in the incubation mixture shifted the urea transition curve towards higher urea concentrations, being higher in the presence of honey and transformed the two-step, three-state transition into a single-step, two-state transition. A comparison of the far-UV CD and the ANS fluorescence spectra of 4.

View Article and Find Full Text PDF

Binding characteristics of a promising anticancer drug, axitinib (AXT) to human serum albumin (HSA), the major transport protein in human blood circulation, were studied using fluorescence, UV-vis absorption and circular dichroism (CD) spectroscopy as well as molecular docking analysis. A gradual decrease in the Stern-Volmer quenching constant with increasing temperature revealed the static mode of the protein fluorescence quenching upon AXT addition, thus confirmed AXT-HSA complex formation. This was also confirmed from alteration in the UV-vis spectrum of HSA upon AXT addition.

View Article and Find Full Text PDF
Article Synopsis
  • This study explored how the anticancer drug lapatinib (LAP) interacts with human serum albumin (HSA), a key transport protein in the blood, using fluorescence and circular dichroism (CD) techniques as well as molecular docking.
  • The binding of LAP to HSA showed a moderate affinity, with specific interactions like hydrophobic forces and hydrogen bonds playing a significant role, alongside structural changes in HSA confirmed through CD analysis.
  • The research also indicated that LAP preferentially binds to a specific site on HSA and that the presence of metal ions can reduce this binding affinity.
View Article and Find Full Text PDF